Franco Mandelli focuses on Internal medicine, Surgery, Leukemia, Chemotherapy and Gastroenterology. His research integrates issues of Acute promyelocytic leukemia and Oncology in his study of Internal medicine. His work on Bone marrow expands to the thematically related Surgery.
The study incorporates disciplines such as Myeloid and Cancer research in addition to Leukemia. Franco Mandelli interconnects Regimen, Prednisone and Lymphoma in the investigation of issues within Chemotherapy. His studies in Gastroenterology integrate themes in fields like Maintenance therapy, Pathology, Induction chemotherapy, Alpha interferon and Multiple myeloma.
The scientist’s investigation covers issues in Internal medicine, Surgery, Gastroenterology, Leukemia and Chemotherapy. His biological study spans a wide range of topics, including Immunology and Oncology. Surgery connects with themes related to Bone marrow in his study.
His Gastroenterology research incorporates themes from Alpha interferon, Toxicity and Pathology. The various areas that he examines in his Leukemia study include Acute promyelocytic leukemia and Myeloid. His work deals with themes such as Radiation therapy, Acute lymphocytic leukemia and Lymphoma, which intersect with Chemotherapy.
His main research concerns Internal medicine, Quality of life, Surgery, Oncology and Leukemia. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Immunology and Acute promyelocytic leukemia. His Acute promyelocytic leukemia research integrates issues from Idarubicin and Tretinoin.
His work carried out in the field of Quality of life brings together such families of science as Observational study, Myelodysplastic syndromes, Physical therapy, Pediatrics and Comorbidity. His Surgery research is multidisciplinary, incorporating perspectives in Interferon, Incidence and Toxicity. His Leukemia research is multidisciplinary, relying on both Myeloid, Cancer research, Clinical trial and Induction chemotherapy.
Franco Mandelli mainly investigates Internal medicine, Myeloid leukemia, Quality of life, Leukemia and Surgery. His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Etoposide. His work on Imatinib as part of general Myeloid leukemia research is frequently linked to Social support, bridging the gap between disciplines.
His Quality of life research incorporates elements of Observational study, MEDLINE, Psychiatry, Intensive care medicine and Myelodysplastic syndromes. His Leukemia study incorporates themes from Acute promyelocytic leukemia, Hematology, Randomized controlled trial, Tretinoin and Induction chemotherapy. His research in Surgery intersects with topics in Gastroenterology, Incidence and Toxicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Brunangelo Falini;Christina Mecucci;Enrico Tiacci;Myriam Alcalay.
The New England Journal of Medicine (2005)
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede.
The New England Journal of Medicine (2013)
Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia
R. A. Zittoun;F. Mandelli;R. Willemze;T. De Witte.
The New England Journal of Medicine (1995)
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.
Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati.
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati.
The New England Journal of Medicine (1997)
Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy
Franco Mandelli;Daniela Diverio;Giuseppe Avvisati;Anna Luciano.
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun.
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
Sabina Chiaretti;Sabina Chiaretti;Xiaochun Li;Xiaochun Li;Robert Gentleman;Robert Gentleman;Antonella Vitale;Antonella Vitale.
A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia
Hervé Dombret;Claude Chastang;Pierre Fenaux;Josy Reiffers.
The New England Journal of Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: